berotek has been researched along with deflazacort in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bagnasco, M; Canonica, GW; Ciprandi, G; Scordamaglia, A | 1 |
1 review(s) available for berotek and deflazacort
| Article | Year |
|---|---|
Drugs and the immune response: knowledge and perspectives in allergology.
Topics: Anti-Inflammatory Agents; Antibody Formation; Cromolyn Sodium; Dexamethasone; Fenoterol; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Immune System; Lymphocyte Activation; Pirenzepine; Prednisone; Pregnenediones; Prostanoic Acids; T-Lymphocytes | 1989 |
2 other study(ies) available for berotek and deflazacort
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |